MedPath
NMPA Approval

Bivalirudin for Injection

国药准字H20244244

June 28, 2024

Drug Information

注射用比伐芦定

注射剂

0.25g(按C₉₈H₁₃₈N₂₄O₃₃计)

化学药品

June 28, 2024

Company Information

Applicant Company

海口市南海大道168号海口保税区

Manufacturing Company

海南省海口市南海大道168号保税区内

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用比伐芦定 - NMPA 批准文号 | MedPath